Claritev (NYSE: CTEV) CEO Dalton buys about $150,000 of shares via spouse’s IRA

What happened

Claritev Corp (NYSE: CTEV) CEO Travis Dalton bought 5,110 Class A shares on Nov. 11 for about $149,927.

The Form 4 lists Dalton as president, CEO, executive chair and a director of the company. The shares went into a spouse's individual retirement account, which held 57,432 Class A shares afterward.

The $29.34 per-share price is a weighted average. Dalton bought the shares in multiple transactions at prices from $29.20 to $29.50, the filing says. Kent Bartholomew signed the form as attorney-in-fact on Nov. 13, two days after the trade.

Key numbers

Metric Latest Change Source
Class A shares bought Nov. 11 5,110 shares SEC Form 4
Weighted average price per share $29.34 SEC Form 4
Total purchase value about $149,927 SEC Form 4
Spouse's IRA holding after purchase 57,432 shares +9.8% Calculated from SEC Form 4
Class A shares held directly 498,353 shares SEC Form 4

Read more: Claritev (CTEV) company research

Why it matters

By OptimistFi's calculation, the purchase added 9.8% to the 52,322 shares the account held before the trade. That is a clear increase for that account, though small beside the 498,353 Class A shares Dalton holds directly.

OptimistFi has argued that Claritev's embedded pre-payment claims workflow must keep producing payer savings fast enough to rebuild margins and service a highly levered balance sheet. A CEO adding shares leans toward that case, but only modestly.

The purchase is reported as indirect ownership, separate from the direct position. Dalton is both an officer and a director, so the buyer sits in management and the boardroom. The purchase was built in pieces across a 30-cent price range, not in one block.

It is a single purchase and does not by itself prove better operating performance or stronger fundamentals. It leaves the leverage question in the case untouched. One buyer, one trade date and one account limit what the purchase can say about the company.

Stock perps: every US stock that trades as a perpetual future, by leverage, live

What's next

Claritev's next quarterly report is the next test of the case. Investors will look for payer savings from the pre-payment claims workflow and for rising margins, since the case ties both to servicing the company's debt.

Stronger margins would support the purchase as a read on the business. Flat or weaker margins would leave it as the only positive datapoint, and a small one.

More from OptimistFi

From OptimistFi Perps

Sources

Explore OptimistFi research on Claritev Corp: https://optimistfi.com/stocks/CTEV

Browse Claritev Corp company coverage and explore the OptimistFi Thesis-Break Engine.

Browse every company OptimistFi covers at optimistfi.com/stocks, or read the latest evidence-first research.

Find available research on the Claritev Corp company page.

Originally published on OptimistFi, evidence-first equity research. More at optimistfi.com.